Literature DB >> 16839695

Cognitive interviews for measurement evaluation of the Fagerström Test for Nicotine Dependence (FTND) in smokers with schizophrenia spectrum disorders.

Judith J Prochaska1, Desiree N Leek, Stephen E Hall, Sharon M Hall.   

Abstract

People diagnosed with schizophrenia have among the highest known rates of tobacco use. While the Fagerström Test for Nicotine Dependence (FTND) is the most widely used measure of nicotine dependence, recent research has questioned its applicability for individuals with schizophrenia. The current study employed cognitive interviews to evaluate the FTND with smokers diagnosed with schizophrenia spectrum disorders, recruited from an acute inpatient psychiatry setting, and a comparison group of smokers recruited from the community. The groups were comparable on tobacco use variables and FTND scores. Detailed qualitative cognitive interviews indicated all subjects understood the FTND items. For both groups, the FTND missed nocturnal smoking, reported as weekly by 80% of patients and 47% of controls. Finishing other people's cigarettes also was under-reported on the FTND. Restrictions to smoking were common across groups. The cognitive interview methodology proved useful for understanding how individuals interpreted and answered the FTND items. Overall, the qualitative findings identified limitations in the FTND for both groups, with the limitations generally more pronounced among patients with schizophrenia.

Entities:  

Mesh:

Year:  2006        PMID: 16839695     DOI: 10.1016/j.addbeh.2006.06.016

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  6 in total

1.  Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia.

Authors:  Jill M Williams; Kunal K Gandhi; Shou-En Lu; Supriya Kumar; Marc L Steinberg; Brett Cottler; Neal L Benowitz
Journal:  Drug Alcohol Depend       Date:  2011-05-18       Impact factor: 4.492

2.  PTSD symptomatology and readiness to quit smoking among women with serious mental illness.

Authors:  Kelly C Young-Wolff; Sebastien C Fromont; Kevin Delucchi; Stephen E Hall; Sharon M Hall; Judith J Prochaska
Journal:  Addict Behav       Date:  2014-04-05       Impact factor: 3.913

3.  Multiple risk-behavior profiles of smokers with serious mental illness and motivation for change.

Authors:  Judith J Prochaska; Sebastien C Fromont; Kevin Delucchi; Kelly C Young-Wolff; Neal L Benowitz; Stephen Hall; Thomas Bonas; Sharon M Hall
Journal:  Health Psychol       Date:  2014-01-27       Impact factor: 4.267

4.  Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.

Authors:  Arthur L Brody; Todd Zorick; Robert Hubert; Gerhard S Hellemann; Shabnam Balali; Sarah S Kawasaki; Lizette Y Garcia; Ryutaro Enoki; Paul Abraham; Paulina Young; Charles McCreary
Journal:  Nicotine Tob Res       Date:  2016-08-03       Impact factor: 4.244

5.  Nicotine dependence in Croatian male inpatients with schizophrenia.

Authors:  Marina Šagud; Bjanka Vuksan-Ćusa; Nenad Jakšić; Alma Mihaljević-Peleš; Maja Živković; Suzana Vlatković; Tea Prgić; Darko Marčinko; Wei Wang
Journal:  BMC Psychiatry       Date:  2018-01-22       Impact factor: 3.630

6.  Effect of nicotine dependence on quality of life and sleep quality in patients with lung cancer who continue to smoke after diagnosis.

Authors:  Fen Gu; Xue-Fei Li; Jin-Fu Xu; Guang-Hui Gao; Yi-Fan Wu; Cai-Cun Zhou
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.